Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Antech Diagnostics has added a renal biomarker for symmetric dimethylarginine (SDMA) to its offering of products for companion animals.
Antech Diagnostics is aiming to add to its portfolio by launching a test for inflammatory bowel disease (IBD) in dogs this year.
Zomedica Pharmaceuticals has filed a US patent application to boost its intellectual property in the area of fecal parasite detection.
Zoetis has made its third recent purchase in the veterinary reference laboratory space with the capture of Ethos Diagnostic Science.
The US Swine Health Information Center (SHIC) has invested an undisclosed amount in the development of diagnostic tools for swine acute diarrhea syndrome coronavirus (SADS-CoV).
The Animal Pharm Awards 2019 has brought victories for Zoetis, MSD Animal Health, Antech Diagnostics, Virbac, Dechra Pharmaceuticals and others.
Heska has now become the leading company in some important European markets following recent transactions.
Zomedica Pharmaceuticals is shifting tactics to concentrate on its veterinary diagnostics, which should go on sale before the end of the year.
A new portable device from a European research partnership has been proven to detect various poultry diseases in less than one hour.
Michigan-based Zomedica Pharmaceuticals has finalized the development and manufacturing milestones for its canine cancer liquid biopsy platform.
IDEXX Laboratories has introduced a digital cytology service that links veterinarians to over 100 clinical pathologists and enables them to receive results within two hours.
Antech Diagnostics has now delivered predictive insight into individual feline future chronic kidney disease (CKD) status over 100,000 times.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.